Prediction Models for COVID-19 Integrating Age Groups, Gender, and Underlying Conditions
Source abstract
Abstract
The COVID-19 pandemic has caused hundreds of thousands of deaths, millions of infections worldwide, and the loss of trillions of dollars for many large economies. It poses a grave threat to the human population with an excessive number of patients constituting an unprecedented challenge with which health systems have to cope. Researchers from many domains have devised diverse approaches for the timely diagnosis of COVID-19 to facilitate medical responses. In the same vein, a wide variety of research studies have investigated underlying medical conditions for indicators suggesting the severity and mortality of, and role of age groups and gender on, the probability of COVID-19 infection. This study aimed to review, analyze, and critically appraise published works that report on various factors to explain their relationship with COVID-19. Such studies span a wide range, including descriptive analyses, ratio analyses, cohort, prospective and retrospective studies. Various studies that describe indicators to determine the probability of infection among the general population, as well as the risk factors associated with severe illness and mortality, are critically analyzed and these findings are discussed in detail. A comprehensive analysis was conducted on research studies that investigated the perceived differences in vulnerability of different age groups and genders to severe outcomes of COVID-19. Studies incorporating important demographic, health, and socioeconomic characteristics are highlighted to emphasize their importance. Predominantly, the lack of an appropriated dataset that contains demographic, personal health, and socioeconomic information implicates the efficacy and efficiency of the discussed methods. Results are overstated on the part of both exclusion of quarantined and patients with mild symptoms and inclusion of the data from hospitals where the majority of the cases are potentially ill.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: COVID-19 Clinical Research Studies · COVID-19 diagnosis using AI · COVID-19 epidemiological studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Hays · Epidemics and Pandemics: Their Impacts on Human History · 200510.5040/9798400647055 ↗
2. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study10.1016/S2213-2600(20)30079-5 ↗
3. W.H. Organization, “Coronavirus disease (COVID-19) dashboard,” 2019, [Online]. Available: https://covid19.who.int/ (Accessed 21 November 2019).
4. Coronavirus crisis: Unemployment and redundancies begin to rise
5. Role of intelligent computing in COVID-19 prognosis: A state-of-the-art review10.1016/j.chaos.2020.109947 ↗
6. Diagnosing COVID-19: The disease and tools for detection10.1021/acsnano.0c02624 ↗
7. Laboratory diagnosis of COVID-19: Current issues and challenges10.1128/JCM.00512-20 ↗
8. The role of imaging in the detection and management of COVID-19: A review
9. Prediction models for diagnosis and prognosis of COVID-19: Systematic review and critical appraisal10.1136/bmj.m1328 ↗
10. Imaging in corona virus disease 2019 (COVID-19)—A scoping review10.1016/j.ejro.2020.100237 ↗
11. Coronavirus disease 2019 (COVID-19): A systematic review of imaging findings in 919 patients10.2214/AJR.20.23034 ↗
12. A mathematical model for the COVID-19 outbreak and its applications10.3390/sym12060990 ↗
13. COVID-19: A comparison of time series methods to forecast percentage of active cases per population10.3390/app10113880 ↗
14. Box · Time Series Analysis: Forecasting and Control · 2015
15. The Holt-winters forecasting procedure
16. Forecasting time series with complex seasonal patterns using exponential smoothing10.1198/jasa.2011.tm09771 ↗
17. Forecasting at scale10.1080/00031305.2017.1380080 ↗
18. DeepAR: Probabilistic forecasting with autoregressive recurrent networks10.1016/j.ijforecast.2019.07.001 ↗
19. A. Alexandrov, K. Benidis, M. Bohlke-Schneider, V. Flunkert, J. Gasthaus et al., “Gluonts: Probabilistic time series models in python,” arXiv preprint arXiv:1906.05264, 2019.
20. B. N. Oreshkin, C. Dmitri, C. Nicolas and B. Yoshua, “N-BEATS: Neural basis expansion analysis for interpretable time series forecasting,” arXiv preprint arXiv:1905.10437, 2019.
21. COVID-19 pandemic prediction for Hungary: A hybrid machine learning approach10.3390/math8060890 ↗
22. Covid-19 predictions using a Gauss model, based on data from April 210.3390/physics2020013 ↗
23. Estimating the risk of COVID-19 death during the course of the outbreak in Korea, February–May 202010.3390/jcm9061641 ↗
24. Forecasting the spread of COVID-19 in Kuwait using compartmental and logistic regression models10.3390/app10103402 ↗
25. Forecasting COVID-19 epidemic in India and high incidence states using SIR and logistic growth models10.1016/j.cegh.2020.06.006 ↗
26. Modeling and forecasting the COVID-19 temporal spread in Greece: An exploratory approach based on complex network defined splines10.3390/ijerph17134693 ↗
27. Modelling the evolution of COVID-19 in high-incidence European countries and regions: Estimated number of infections and impact of past and future intervention measures10.3390/jcm9061825 ↗
28. On a coupled time-dependent SIR models fitting with New York and New-Jersey states COVID-19 data10.3390/biology9060135 ↗
29. Naive forecast for COVID-19 in Utah based on the South Korea and Italy models-the fluctuation between two extremes10.3390/ijerph17082750 ↗
30. On the analysis of new COVID-19 cases in Pakistan using an exponentiated version of the M family of distributions10.3390/math8060953 ↗
31. Predicting the epidemiological outbreak of the Coronavirus disease 2019 (COVID-19) in Saudi Arabia10.3390/ijerph17124568 ↗
32. Prediction of epidemic peak and infected cases for COVID-19 disease in Malaysia
33. Prediction of the epidemic peak of coronavirus disease in Japan
34. Prediction of the number of patients infected with COVID-19 based on rolling grey verhulst models10.3390/ijerph17124582 ↗
35. Multiple ensemble neural network models with fuzzy response aggregation for predicting COVID-19 time series: The case of Mexico10.3390/healthcare8020181 ↗
36. Statistical explorations and univariate timeseries analysis on COVID-19 datasets to understand the trend of disease spreading and death10.3390/s20113089 ↗
37. Prediction of number of cases of 2019 novel coronavirus (COVID-19) using social media search index10.3390/ijerph17072365 ↗
38. Unfolding events in space and time: Geospatial insights into COVID-19 diffusion in Washington state during the initial stage of the outbreak10.3390/ijgi9060382 ↗
39. Viral infections and asthma: An inflammatory interface?
40. Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis10.1016/j.rmed.2020.106020 ↗
41. Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza10.1183/13993003.00949-2019 ↗
42. Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization10.1016/j.rmed.2020.106084 ↗
43. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?10.1016/S2213-2600(20)30167-3 ↗
44. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells10.1016/j.resinv.2019.12.005 ↗
45. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc
46. Covid-19 and heart: From clinical features to pharmacological implications10.3390/jcm9061944 ↗
47. Coping with COVID-19: Exposure to COVID-19 and negative impact on livelihood predict elevated mental health problems in Chinese adults10.3390/ijerph17113857 ↗
48. Coronavirus outbreak and stress in Iranians10.3390/ijerph17124441 ↗
49. Depression and anxiety in Hong Kong during COVID-1910.3390/ijerph17103740 ↗
50. Depression, anxiety and stress during COVID-19: Associations with changes in physical activity, sleep, tobacco and alcohol use in Australian adults10.3390/ijerph17114065 ↗
51. Depression, anxiety, stress levels of physicians and associated factors in Covid-19 pandemics10.1016/j.psychres.2020.113130 ↗
52. Effects of Covid-19 lockdown on mental health and sleep disturbances in Italy10.3390/ijerph17134779 ↗
53. Factors associated with COVID-19 outbreak-related suicides in India10.1016/j.ajp.2020.102223 ↗
54. Effects of the COVID-19 lockdown on human sleep and rest-activity rhythms10.1016/j.cub.2020.06.021 ↗
55. The enemy which sealed the world: Effects of COVID-19 diffusion on the psychological state of the Italian population10.3390/jcm9061802 ↗
56. Health anxiety, cyberchondria, and coping in the current COVID-19 pandemic: Which factors are related to coronavirus anxiety?10.1016/j.janxdis.2020.102239 ↗
57. COVID-19-related factors associated with sleep disturbance and suicidal thoughts among the Taiwanese public: A Facebook survey10.3390/ijerph17124479 ↗
58. Related health factors of psychological distress during the COVID-19 pandemic in Spain10.3390/ijerph17113947 ↗
59. An investigation of mental health status of children and adolescents in china during the outbreak of COVID-1910.1016/j.jad.2020.06.029 ↗
60. Prevalence and predictors of anxiety and depression symptoms during the COVID-19 pandemic and compliance with precautionary measures: Age and sex matter10.3390/ijerph17144924 ↗
61. Cardiac involvement in systemic inflammatory diseases10.1093/eurheartj/ehm193 ↗
62. Cholesterol in relation to COVID-19: Should we care about it?10.3390/jcm9061909 ↗
63. Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic10.5114/aoms.2020.94503 ↗
64. Y. Wang, Y. Zong, F. Yin, X. Yang, H. Zhong et al., “Cholesterol metabolism—Impacts on SARS-CoV-2 infection prognosis,” medRxiv, 2020. Preprint, https://doi.org/10.1101/2020.04.16.20068528.10.1101/2020.04.16.20068528 ↗
65. Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: A systematic review10.1016/j.dsx.2020.07.005 ↗
66. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention10.1001/jama.2020.2648 ↗
67. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)10.1001/jamacardio.2020.1017 ↗
68. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study10.1016/S0140-6736(20)30211-7 ↗
69. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, Chinaa10.1001/jama.2020.1585 ↗
70. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China10.1007/s00134-020-05991-x ↗
71. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19
72. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study10.1016/S0140-6736(20)30566-3 ↗
73. COVID-19 in Italy: Momentous decisions and many uncertainties10.1016/S2214-109X(20)30110-8 ↗
74. Coronavirus: Older persons with cancer in Italy in the COVID-19 pandemic10.3389/fonc.2020.00648 ↗
75. Clinical features and short-term outcomes of elderly patients with COVID-1910.1016/j.ijid.2020.05.107 ↗
76. COVID-19 in seniors: Findings and lessons from mass screening in a nursing home10.1016/j.maturitas.2020.06.023 ↗
77. Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study10.1016/j.jcv.2020.104378 ↗
78. Sex differences in COVID-19 case fatality rate: Insights from a multinational registry10.1016/j.mayocp.2020.05.014 ↗
79. Short-term outcomes in individuals aged 75 or older with severe coronavirus disease (COVID-19): First observations from an infectious diseases unit in Southern Italy10.1016/j.jinf.2020.05.024 ↗
80. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area10.1001/jama.2020.6775 ↗
81. Factors associated with prolonged viral RNA shedding in patients with COVID-1910.1093/cid/ciaa351 ↗
82. Kidney disease is associated with in-hospital death of patients with COVID-1910.1016/j.kint.2020.03.005 ↗
83. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China
84. Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease10.1016/j.metabol.2020.154244 ↗
85. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up10.1016/j.jinf.2020.03.019 ↗
86. Potential of age distribution profiles for the prediction of COVID-19 infection origin in a patient group10.1016/j.imu.2020.100364 ↗
87. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy10.1001/jama.2020.5394 ↗
88. Are we equal in adversity? Does Covid-19 affect women and men differently?10.1016/j.maturitas.2020.05.009 ↗
89. Characteristics of asymptomatic patients with SARS-CoV-2 infection in Jinan, China10.1016/j.micinf.2020.04.011 ↗
90. Gender differences in patients with COVID-19: Focus on severity and mortality10.3389/fpubh.2020.00152 ↗
91. Impact of gender on extent of lung injury in COVID-1910.1016/j.crad.2020.04.005 ↗
92. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 202010.1016/j.cca.2020.03.009 ↗
93. Gender-based disparities in COVID-19: Clinical characteristics and propensity-matched analysis of outcomes
94. COVID-19 in critically ill patients in the Seattle region—Case series10.1056/NEJMoa2004500 ↗
95. COVID-19: The gendered impacts of the outbreak10.1016/S0140-6736(20)30526-2 ↗
96. S. Hernandez, M. Carlos and M. Z. Efren, “Statistics associated with the lethality of COVID-19 by age group and gender in Mexico,” medRxiv, 2020. Preprint, https://doi.org/10.1101/2020.06.28.20142117.10.1101/2020.06.28.20142117 ↗
97. Health care and mental health challenges for transgender individuals during the COVID-19 pandemic10.1016/S2213-8587(20)30182-0 ↗
98. J. L. Herman and K. O’Neill, “Vulnerabilities to COVID-19 among transgender adults in the US,” 2020. [Online]. Available: https://escholarship.org/content/qt55t297mc/qt55t297mc.pdf.
99. Mental health needs among lesbian, gay, bisexual, and transgender college students during the COVID-19 pandemic10.1016/j.jadohealth.2020.08.006 ↗
100. Effects of COVID-19 infection during pregnancy and neonatal prognosis: What is the evidence?10.3390/ijerph17114176 ↗